Cell-to-cell/JJ
contact/NN
activates/VBZ
the/DT
long/JJ
terminal/JJ
repeat/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
1/CD
through/IN
its/PRP$
kappaB/NN
motif/NN
./.

Cell-to-cell/JJ
contact/NN
between/IN
peripheral/JJ
blood/NN
lymphocytes/NNS
and/CC
transfected/VBN
human/JJ
colonic/JJ
carcinoma/NN
cell/NN
line/NN
HT29/NN
activates/VBZ
transcription/NN
of/IN
the/DT
long/JJ
terminal/JJ
repeats/NNS
(/(
LTR/NNS
)/)
of/IN
human/JJ
immunodeficiency/NN
virus/NN
./.
=====
HIV-1/NN
LTR/NNS
transcription/NN
is/VBZ
controlled/VBN
by/IN
a/DT
complex/JJ
array/NN
of/IN
virus-encoded/JJ
and/CC
cellular/JJ
proteins/NNS
./.
=====
Using/VBG
various/JJ
constructs/NNS
expressing/VBG
a/DT
lacZ/NN
reporter/NN
gene/NN
under/IN
the/DT
control/NN
of/IN
the/DT
intact/JJ
or/CC
three/CD
deleted/JJ
forms/NNS
of/IN
HIV-1/NN
LTR/NNS
,/,
we/PRP
obtained/VBD
evidence/NN
that/IN
the/DT
kappaB/NN
regulatory/JJ
elements/NNS
located/JJ
in/IN
the/DT
U3/NN
region/NN
are/VBP
involved/VBN
in/IN
cell-to-cell/JJ
activation/NN
of/IN
HIV-1/NN
LTR/NNS
./.
=====
Cell-to-cell/JJ
contact/NN
activates/VBZ
in/FW
vitro/FW
binding/NN
of/IN
the/DT
nuclear/JJ
factor/NN
kappaB/NN
(/(
NF-kappaB/NN
)/)
p50/p65/NN
heterodimer/NN
to/TO
an/DT
HIV-1/NN
kappaB/NN
oligonucleotide/NN
./.
=====
Cell-to-cell/JJ
contact/NN
activation/NN
of/IN
NF-kappaB/NN
was/VBD
only/RB
partially/RB
inhibited/VBN
by/IN
100/CD
microM/NN
pyrrolidine/NN
dithiocarbamate/NN
and/CC
was/VBD
not/RB
correlated/VBN
with/IN
a/DT
significant/JJ
decrease/NN
of/IN
cellular/JJ
inhibitor/NN
kappaB/NN
alpha/NN
./.
=====
NF-kappaB/NN
nuclear/JJ
activation/NN
was/VBD
not/RB
detectable/JJ
before/IN
1/CD
h/NN
after/IN
cell/NN
contact/NN
and/CC
was/VBD
dependent/JJ
on/IN
protein/NN
synthesis/NN
./.